Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1990 Jul;65(7):782–785. doi: 10.1136/adc.65.7.782

Effective bronchodilator treatment by a simple spacer device for wheezy premature infants.

B Yuksel 1, A Greenough 1, I Maconochie 1
PMCID: PMC1792447  PMID: 2091630

Abstract

Ten preterm infants with recurrent respiratory symptoms (median gestational age 30 weeks) were entered into a non-randomised placebo controlled trial of bronchodilator treatment at 12.5 months of age. The infants had coughed or wheezed, or both, on at least four days a week for the past month. The infants received either placebo or 500 micrograms terbutaline from an inhaler using a coffee cup as a spacer device. Each treatment was maintained for two weeks, first placebo then active drug. The symptom score was reduced by 65% during the active treatment period compared with the placebo period and this was associated with a 32% improvement in lung function, reflected in an increase in functional residual capacity. We conclude that inhaled bronchodilator treatment given with a simple spacer device is useful for preterm infants with recurrent respiratory symptoms in the first two years of life.

Full text

PDF
782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andréasson B., Lindroth M., Mortensson W., Svenningsen N. W., Jonson B. Lung function eight years after neonatal ventilation. Arch Dis Child. 1989 Jan;64(1):108–113. doi: 10.1136/adc.64.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benton G., Thomas R. C., Nickerson B. G., McQuitty J. C., Okikawa J. Experience with a metered-dose inhaler with a spacer in the pediatric emergency department. Am J Dis Child. 1989 Jun;143(6):678–681. doi: 10.1001/archpedi.1989.02150180056020. [DOI] [PubMed] [Google Scholar]
  3. Bowman E., Yu V. Y. Continuing morbidity in extremely low birthweight infants. Early Hum Dev. 1988 Dec;18(2-3):165–174. doi: 10.1016/0378-3782(88)90053-9. [DOI] [PubMed] [Google Scholar]
  4. Conner W. T., Dolovich M. B., Frame R. A., Newhouse M. T. Reliable salbutamol administration in 6- to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol. 1989;6(4):263–267. doi: 10.1002/ppul.1950060410. [DOI] [PubMed] [Google Scholar]
  5. Gaultier C., Boulé M., Allaire Y., Clément A., Girard F. Growth of lung volumes during the first three years of life. Bull Eur Physiopathol Respir. 1979;15(6):1103–1116. [PubMed] [Google Scholar]
  6. Greenough A., Pool J., Price J. F. Changes in functional residual capacity in response to bronchodilator therapy among young asthmatic children. Pediatr Pulmonol. 1989;7(1):8–11. doi: 10.1002/ppul.1950070104. [DOI] [PubMed] [Google Scholar]
  7. Greenspan J. S., Abbasi S., Bhutani V. K. Sequential changes in pulmonary mechanics in the very low birth weight (less than or equal to 1000 grams) infant. J Pediatr. 1988 Oct;113(4):732–737. doi: 10.1016/s0022-3476(88)80391-3. [DOI] [PubMed] [Google Scholar]
  8. Lenney W., Milner A. D. At what age do bronchodilator drugs work? Arch Dis Child. 1978 Jul;53(7):532–535. doi: 10.1136/adc.53.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. O'Brodovich H. M., Mellins R. B. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis. 1985 Sep;132(3):694–709. doi: 10.1164/arrd.1985.132.3.694. [DOI] [PubMed] [Google Scholar]
  10. O'Callaghan C., Milner A. D., Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986 Dec 20;2(8521-22):1424–1425. doi: 10.1016/s0140-6736(86)92735-2. [DOI] [PubMed] [Google Scholar]
  11. O'Callaghan C., Milner A. D., Swarbrick A. Spacer device with face mask attachment for giving bronchodilators to infants with asthma. BMJ. 1989 Jan 21;298(6667):160–161. doi: 10.1136/bmj.298.6667.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Park E. S., Golding J., Carswell F., Stewart-Brown S. Preschool wheezing and prognosis at 10. Arch Dis Child. 1986 Jul;61(7):642–646. doi: 10.1136/adc.61.7.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pierce A. K., Sanford J. P., Thomas G. D., Leonard J. S. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. N Engl J Med. 1970 Mar 5;282(10):528–531. doi: 10.1056/NEJM197003052821002. [DOI] [PubMed] [Google Scholar]
  14. Prendiville A., Green S., Silverman M. Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors. Thorax. 1987 Feb;42(2):100–104. doi: 10.1136/thx.42.2.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sauve R. S., Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics. 1985 Nov;76(5):725–733. [PubMed] [Google Scholar]
  16. Smyth J. A., Tabachnik E., Duncan W. J., Reilly B. J., Levison H. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics. 1981 Sep;68(3):336–340. [PubMed] [Google Scholar]
  17. Sosulski R., Abbasi S., Bhutani V. K., Fox W. W. Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 1986 Sep-Oct;2(5):269–273. doi: 10.1002/ppul.1950020504. [DOI] [PubMed] [Google Scholar]
  18. Wilkie R. A., Bryan M. H. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr. 1987 Aug;111(2):278–282. doi: 10.1016/s0022-3476(87)80087-2. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES